Revenue
attach_money172M USD
YoY +627.8%
SNDXSyndax Pharmaceuticals, Inc.$ --
Syndax Pharmaceuticals, Inc.
SNDX
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 12/31/2025
Operating Income
bar_chart-273M USD
YoY +19.6%
Net Income
verified-285M USD
YoY +10.5%
EPS
pie_chart-3.29USD
YoY +11.8%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress34.9%On Track
Revenue Progress64.9M
Revenue Forecast366.8M
Net Income Progress-42.7M
Net Income Forecast-122.3M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.